ALPHAEON Acquires Exclusive United States License To TEOXANE Laboratories' Full Portfolio Of Next-Generation Dermal Fillers And Cosmeceutical Products

NEWPORT BEACH, Calif., Aug. 2, 2013 /PRNewswire/ -- ALPHAEON Corporation, a leader in lifestyle healthcare and a wholly-owned subsidiary of Strathspey Crown Holdings, LLC, announced today that it has acquired an exclusive United States license for the full line of products from Geneva-based TEOXANE Laboratories. Known for high-quality, market-leading products, TEOXANE Laboratories is recognized as an innovator of hyaluronic acid-based wrinkle-filling products currently available in 90 markets outside of the United States.

"The partnership with TEOXANE Laboratories is a great fit for ALPHAEON, as both companies possess an unparalleled commitment to delivering science-based, high-quality medical aesthetic products," said Robert E. Grant, chief executive officer (CEO) of ALPHAEON. "During the past ten years, TEOXANE has gained significant market presence and leadership in Europe, capturing the number two market position in several western European countries for its broad range of next-generation hyaluronic acid dermal fillers and innovative cosmeceuticals. The TEOXANE transaction advances ALPHAEON's vision to bring highly innovative lifestyle healthcare products, combined with value-added services, to serve patients." Mr. Grant noted that in addition to the partnership agreement, TEOXANE Founder and Chairwoman Valerie Taupin will join the ALPHAEON Board of Directors. "We are honored to have an executive leader with such a tremendous track record of medical aesthetic innovation and entrepreneurship join our Board of Directors."

"Physicians in the United States have been asking us to bring our innovative products to the U.S. market for many years," said Madame Taupin. "ALPHAEON brings together an impressive team of medical aesthetic leaders who share TEOXANE's commitment to excellence, innovation and patient satisfaction. Following a long and competitive review process, ALPHAEON emerged as the clear choice for our U.S. partnership, based on their leadership team's prior unprecedented track record of success driving double digit growth of BOTOX^® Cosmetic and bringing to market such leading aesthetic product brands as JUVEDERM^®. We look forward to a very successful long-term relationship."  

As part of the relationship, ALPHAEON will market the full line of TEOXANE hyaluronic acid-based dermal fillers and cosmeceutical products to credentialed physician specialists (CPSs). Other terms of the license acquisition are not being disclosed.

TEOXANE products contain 100 percent non-animal origin, resorbable hyaluronic acid. Hyaluronic acid dermal fillers are the most widely used aesthetic fillers worldwide.

About ALPHAEON 
ALPHAEON is a lifestyle healthcare company that brings to market highly innovative products and services to promote consumer wellness, beauty and performance. Ensuring access to leading advancements in lifestyle healthcare, the company fosters deep relationships with leading credentialed physician specialists so healthcare consumers look their best, feel their best and know they are receiving the best in lifestyle healthcare. ALPHAEON is an operating company that is wholly-owned by Strathspey Crown Holdings, LLC. For more information visit www.alphaeon.com.

About Strathspey Crown 
Strathspey Crown is a growth equity firm specializing in lifestyle healthcare. Strathspey Crown uniquely partners with credentialed physician specialists (CPSs) to bring to market highly innovative technologies and services in the self-pay sector. The firm is founded in partnership with physician investors across three key medical specialties: plastic surgery, ophthalmology and dermatology. For more information visit www.strathspeycrown.com.

About TEOXANE Laboratories
TEOXANE Laboratories, established in Geneva in 2003, specializes in the design and manufacture of hyaluronic acid-based wrinkle-filling products. As a result of its uncompromising commitment to innovation, quality and patient satisfaction, TEOXANE is now among the top three hyaluronic acid-based wrinkle product manufacturers in the world. With products in more than 90 countries, its alliance with U.S.-based ALPHAEON will bring its full line of products to market in the United States.

PRESS CONTACTS:  
Jenna Mons, Director of Marketing and Communications  
Tel: +1 949.260.1700 
Email: [email protected]

^{BOTOX® Cosmetic and JUVEDERM® are registered trademarks of Allergan, Inc.}

SOURCE ALPHAEON Corporation